文献速递甲状腺疾病

中国甲状腺癌流行病学概况与过度诊断估计:一项基于人群的研究

The Epidemiological Landscape of Thyroid Cancer and Estimates of Overdiagnosis in China: A Population-Based Study.
PubMed 文献 · Thyroid · 2025-02-19

该研究基于五大洲癌症发病率数据库,分析中国甲状腺癌年龄标化发病率趋势,并用年龄-时期-队列模型及年龄别曲线形态比较估算过度诊断所致发病率。1993至2017年男女发病率均显著上升,2013至2017年过度诊断分别占男性83.5%、女性88.7%的病例,且城市显著高于农村、省份间差异明显。

要点

  • 1993至2017年中国甲状腺癌发病率显著上升,男性平均年度变化百分比14.7%、女性16.2%。
  • 2013至2017年过度诊断占男性甲状腺癌83.5%(31,455/37,685)、女性88.7%(104,222/117,509)。
  • 过度诊断所致发病率城市(男性6.9/10万、女性21.7/10万)显著高于农村(男性1.3/10万、女性6.4/10万)。

核心结论

  • 过去25年中国甲状腺癌发病率大幅上升,过度诊断所致发病率快速增加且存在明显地理差异,提示需调整甲状腺癌筛查策略与临床实践、优化医疗资源配置并监测过度诊断对人群健康的影响。

研究设计与样本

  • 基于五大洲癌症发病率数据库的人群研究,计算世界标准人口年龄标化发病率(ASIR),采用Joinpoint回归和年龄-时期-队列模型分析时间趋势与时期效应,并通过比较15至84岁患者年龄别曲线形态与诊断实践前观察到的曲线来估算过度诊断所致发病率。

主要发现

  • 2013至2017年中国男性新发甲状腺癌37,862例、女性117,979例,ASIR分别为6.9/10万和21.1/10万。
  • 1993至2017年发病率显著上升,男性平均年度变化百分比14.7%、女性16.2%;时期效应发病率比从1.0升至男性61.8、女性42.9。
  • 2013至2017年过度诊断占男性83.5%(31,455/37,685)、女性88.7%(104,222/117,509),相应ASIR为男性5.9/10万、女性19.1/10万。
  • 过度诊断所致ASIR城市男性6.9/10万、女性21.7/10万,显著高于农村男性1.3/10万、女性6.4/10万。
  • 25个纳入省份中,过度诊断所致ASIR男性从四川0.3/10万到上海18.5/10万,女性从山西0.1/10万到上海49.4/10万;全国男性从2008至2012年2.6/10万升至2013至2017年5.9/10万,女性从9.2/10万升至19.1/10万。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: In China, thyroid cancer (TC) is the most common cancer in females and the fifth most common cancer in males. TC overdiagnosis leads to overtreatment, lifelong medical care, and side effects. This study systematically quantifies the epidemiological profile of TC incidence in China, as well as estimating TC incidence attributable to overdiagnosis. Methods: Data were derived from the Cancer Incidence in Five Continents databases. Age-standardized incidence rates (ASIRs) per 100,000 person-years were calculated using the world standard population. Joinpoint regression and age-period-cohort models were conducted to examine temporal ASIR trends and period effects, respectively. We estimated TC incidence attributable to overdiagnosis among patients aged 15-84 years by comparing shapes of age-specific curves with those observed before diagnostic practices. Results: In 2013-2017, there were 37,862 and 117,979 new TC cases in males and females in China, respectively, with ASIRs of 6.9/100,000 and 21.1/100,000. Significant upward trends were observed from 1993 to 2017, with average annual percent changes being 14.7% for males and 16.2% for females. Incidence rate ratios of period effects markedly increased from 1.0 to 61.8 for males and from 1.0 to 42.9 for females from 1993 to 2017. Overdiagnosis accounted for 83.5% (31,455/37,685) and 88.7% (104,222/117,509) of cases in males and females in 2013-2017, respectively, yielding ASIRs of 5.9/100,000 and 19.1/100,000. ASIRs attributable to overdiagnosis in urban populations (6.9/100,000 for males and 21.7/100,000 for females) were significantly higher than in rural populations (1.3/100,000 and 6.4/100,000). Among the 25 included provinces, ASIRs attributable to overdiagnosis ranged from 0.3/100,000 in Sichuan to 18.5/100,000 in Shanghai in males and from 0.1/100,000 in Shanxi to 49.4/100,000 in Shanghai in females. The national ASIRs attributable to overdiagnosis increased from 2.6/100,000 in 2008-2012 to 5.9/100,000 in 2013-2017 for males and from 9.2/100,000 to 19.1/100,000 for females. Conclusions: The incidence rates of TC have considerably increased over the past 25 years in China. Rapidly increasing trends and considerable geographic variations in TC incidence attributable to overdiagnosis highlight the need to adjust TC screening strategies and clinical practices, optimize healthcare resource allocation, and monitor the impacts of TC overdiagnosis on population-level health.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Zhu Q, Liu J, Hu J, et al. The Epidemiological Landscape of Thyroid Cancer and Estimates of Overdiagnosis in China: A Population-Based Study. Thyroid. 2025. PMID: 39970038. doi:10.1089/thy.2024.0583

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。